CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.
about
CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells.Novel treatment strategies for aggressive non-Hodgkin's lymphoma.Hodgkin's lymphoma: molecular targets and novel treatment strategies.Monoclonal antibodies in chronic lymphocytic leukemia.Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis.The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms.The fourth dimension in immunological space: how the struggle for nutrients selects high-affinity lymphocytes.Bezafibrate and medroxyprogesterone acetate target resting and CD40L-stimulated primary marginal zone lymphoma and show promise in indolent B-cell non-Hodgkin lymphomas.CD40·FasL and CTLA-4·FasL fusion proteins induce apoptosis in malignant cell lines by dual signaling.Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate.Novel Molecular Mechanism of Regulation of CD40 Ligand by the Transcription Factor GLI2.DNA damage induced by human CD40 ligand mutant promotes senescence and induces demethylation of GATA4 in lung cancer.
P2860
Q36022324-4DF67791-4002-40DD-ACE5-E1119FBC1ADCQ36429727-DB2EEAB6-EADA-4275-82A9-79E737ECC195Q36572545-8D2D6525-C53F-4F58-9775-9D1DBF1378BEQ36613987-71CD0DD3-84A3-45E3-8576-F7E59EFB0DA6Q36699754-F1915B7D-F37A-4C0F-85DC-C877D7509A98Q37861186-20E4D830-E61F-40DD-A329-46173137150EQ38034268-8DD69239-E750-4EB0-AC3E-0118E1779E47Q38977906-0C4243BE-B2E8-464F-8935-BD5F6577ECE4Q39630040-CDD9AE74-1892-4265-A881-AD0C192EB534Q46829895-454FC17C-4E1B-446B-B9B0-F497AD3DA389Q48210066-E4613D3B-EB23-415F-AE99-3B2CADBCCD0CQ52642947-6A2F8868-DE88-4E8B-83EC-2211577581BA
P2860
CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
CD40 ligand (CD154) and tumour ...... n haematological malignancies.
@ast
CD40 ligand (CD154) and tumour ...... n haematological malignancies.
@en
type
label
CD40 ligand (CD154) and tumour ...... n haematological malignancies.
@ast
CD40 ligand (CD154) and tumour ...... n haematological malignancies.
@en
prefLabel
CD40 ligand (CD154) and tumour ...... n haematological malignancies.
@ast
CD40 ligand (CD154) and tumour ...... n haematological malignancies.
@en
P2860
P1476
CD40 ligand (CD154) and tumour ...... n haematological malignancies.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.2001.02593.X
P407
P577
2001-05-01T00:00:00Z